George Lawrence Mikan III Sells 26,660 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 26,660 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $7.19, for a total value of $191,685.40. Following the completion of the transaction, the chief executive officer now owns 178,756 shares of the company’s stock, valued at approximately $1,285,255.64. This represents a 12.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

George Lawrence Mikan III also recently made the following trade(s):

  • On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The shares were sold at an average price of $7.06, for a total transaction of $11,324.24.
  • On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34.
  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Trading Up 0.3 %

NEUE stock traded up $0.02 during midday trading on Tuesday, hitting $6.92. 16,513 shares of the company’s stock were exchanged, compared to its average volume of 24,929. The firm has a 50 day moving average price of $7.33 and a 200-day moving average price of $5.99. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $8.32. The stock has a market capitalization of $57.33 million, a price-to-earnings ratio of -0.14 and a beta of 0.56.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada lowered their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research note on Monday, December 9th.

View Our Latest Research Report on NeueHealth

Institutional Trading of NeueHealth

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC bought a new position in NeueHealth during the 4th quarter valued at $76,000. Northern Trust Corp raised its stake in shares of NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares in the last quarter. Finally, Partners Group Holding AG bought a new position in shares of NeueHealth during the third quarter worth about $463,000. Institutional investors own 63.88% of the company’s stock.

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Articles

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.